Loading…
High serum level of methylglyoxal-derived AGE, Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine, independently relates to renal dysfunction
Background The dicarbonyl methylglyoxal reacts primarily with arginine residues to form advanced glycation end products, including N δ-(5-hydro-5-methyl-4 -imidazolone-2-yl)-ornithine (MG-H1), which are risk factors for not only diabetic complications but also lifestyle-related disease including ren...
Saved in:
Published in: | Clinical and experimental nephrology 2017-06, Vol.21 (3), p.398-406 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
The dicarbonyl methylglyoxal reacts primarily with arginine residues to form advanced glycation end products, including
N
δ-(5-hydro-5-methyl-4 -imidazolone-2-yl)-ornithine (MG-H1), which are risk factors for not only diabetic complications but also lifestyle-related disease including renal dysfunction. However, the data on serum level and clinical significance of this substance in chronic kidney disease are limited.
Methods
Serum levels of MG-H1 and
N
ε-(carboxymethyl) lysine (CML) in 50 patients with renal dysfunction were measured by liquid chromatography/triple-quadruple mass spectrometry.
Results
The median serum MG-H1 levels in patients with estimated glomerular filtration rate (eGFR) of ≥30, 15–30, and 0.05). On the other hand, MG-H1 levels in patients with HbA1c of |
---|---|
ISSN: | 1342-1751 1437-7799 |
DOI: | 10.1007/s10157-016-1301-9 |